A Surge In Altamira (CYTO) Stock After A Patent Application
Altamira Therapeutics Ltd. (NASDAQ: CYTO) experienced a positive trend in its stock during the latest trading session, rising by 8.57% and concluding at $2.28. This increase was primarily influenced by a significant move related to a patent application made by Altamira. In an announcement, Altamira (CYTO) revealed that it recently submitted a second provisional patent […]